Morgan Stanley’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,000
| Closed | -$4.12K | – | 8075 |
|
|
2023
Q3 | $4.12K | Sell |
8,000
-8,100
| -50% | -$5.66K | ﹤0.01% | 6955 |
|
|
2023
Q2 | $11.4K | Buy |
+16,100
| New | +$14.4K | ﹤0.01% | 6771 |
|
|
2022
Q4 | – | Sell |
-2,575
| Closed | -$3K | – | 8186 |
|
|
2022
Q3 | $3K | Buy |
+2,575
| New | +$5.8K | ﹤0.01% | 7439 |
|
|
2022
Q2 | – | Sell |
-109
| Closed | – | – | 8262 |
|
|
2022
Q1 | $0 | Buy |
+109
| New | +$552 | ﹤0.01% | 8318 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$34 | – | 8318 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 8151 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 7892 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 7632 |
|
|
2020
Q4 | $0 | Sell |
3
-7
| -70% | -$219 | ﹤0.01% | 7183 |
|
|
2020
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 6904 |
|
|
2020
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 6557 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 6520 |
|
|
2019
Q4 | $1K | Buy |
10
+7
| +233% | +$491 | ﹤0.01% | 6613 |
|
|
2019
Q3 | $0 | Sell |
3
-2
| -40% | -$130 | ﹤0.01% | 6847 |
|
|
2019
Q2 | $0 | Sell |
5
-51
| -91% | -$8.85K | ﹤0.01% | 6823 |
|
|
2019
Q1 | $12K | Sell |
56
-214
| -79% | -$86.3K | ﹤0.01% | 6145 |
|
|
2018
Q4 | $93K | Buy |
270
+73
| +37% | +$56.7K | ﹤0.01% | 5583 |
|
|
2018
Q3 | $229K | Sell |
197
-477
| -71% | -$439K | ﹤0.01% | 5392 |
|
|
2018
Q2 | $577K | Sell |
674
-26
| -4% | -$21.6K | ﹤0.01% | 4997 |
|
|
2018
Q1 | $822K | Sell |
700
-678
| -49% | -$749K | ﹤0.01% | 4692 |
|
|
2017
Q4 | $1.27M | Sell |
1,378
-255
| -16% | -$235K | ﹤0.01% | 4378 |
|
|
2017
Q3 | $1.79M | Buy |
1,633
+1,210
| +286% | +$1.38M | ﹤0.01% | 3984 |
|
|
2017
Q2 | $487K | Buy |
423
+88
| +26% | +$107K | ﹤0.01% | 4809 |
|
|
2017
Q1 | $386K | Buy |
335
+243
| +264% | +$235K | ﹤0.01% | 4988 |
|
|
2016
Q4 | $96K | Buy |
92
+50
| +119% | +$22.7K | ﹤0.01% | 5585 |
|
|
2016
Q3 | $17K | Sell |
42
-3
| -7% | -$1.22K | ﹤0.01% | 5964 |
|
|
2016
Q2 | $19K | Sell |
45
-35
| -44% | -$17.1K | ﹤0.01% | 5875 |
|
|
2016
Q1 | $34K | Buy |
80
+30
| +60% | +$11.6K | ﹤0.01% | 5752 |
|
|
2015
Q4 | $29K | Sell |
50
-86
| -63% | -$60.3K | ﹤0.01% | 5917 |
|
|
2015
Q3 | $121K | Buy |
136
+121
| +807% | +$110K | ﹤0.01% | 5333 |
|
|
2015
Q2 | $15K | Buy |
15
+5
| +50% | +$5.86K | ﹤0.01% | 6207 |
|
|
2015
Q1 | $15K | Sell |
10
-325
| -97% | -$412K | ﹤0.01% | 6136 |
|
|
2014
Q4 | $470K | Buy |
335
+317
| +1,761% | +$458K | ﹤0.01% | 4703 |
|
|
2014
Q3 | $22K | Buy |
18
+1
| +6% | +$1.44K | ﹤0.01% | 5980 |
|
|
2014
Q2 | $31K | Sell |
17
-405
| -96% | -$541K | ﹤0.01% | 5913 |
|
|
2014
Q1 | $688K | Buy |
422
+421
| +42,100% | +$880K | ﹤0.01% | 4316 |
|
|
2013
Q4 | $1K | Sell |
1
-178
| -99% | -$284K | ﹤0.01% | 6318 |
|
|
2013
Q3 | $359K | Buy |
+179
| New | +$333K | ﹤0.01% | 4553 |
|
Other funds holding HSTO
Morgan Stanley's HSTO Position: Q4 2023 in Review
Morgan Stanley sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 8,000 shares — an estimated $4.12K sold.
Morgan Stanley first reported a position in HSTO in Q3 2013 and held it in 37 quarters. The position peaked at $1.79M in Q3 2017. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.
- Morgan Stanley reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Morgan Stanley sold 8,000 Histogen Inc. Common Stock shares in Q4 2023, an estimated $4.12K.
- Morgan Stanley first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 37 quarters.
- Morgan Stanley's Histogen Inc. Common Stock position peaked at $1.79M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.